Cargando…
Colchicine May Interfere With the Efficacy of the Adenoviral Vector–Based Vaccine for COVID-19
Under the ongoing COVID-19 pandemic, vaccines have become the crucial players to reduce the spread of the infection. Among them, the ChAdOx1 nCoV-19 vaccine is an adenoviral vector vaccine with an overall efficacy of 70.4% in protection. The engineered adenovirus contains the SARS-CoV-2 spike protei...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950003/ https://www.ncbi.nlm.nih.gov/pubmed/35342313 http://dx.doi.org/10.1177/11795441221081061 |